These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 30132167)

  • 21. Pancreatic panniculitis in a patient with BRCA2 mutation and metastatic pancreatic adenocarcinoma.
    Gandhi RK; Bechtel M; Peters S; Zirwas M; Darabi K
    Int J Dermatol; 2010 Dec; 49(12):1419-20. PubMed ID: 21091678
    [No Abstract]   [Full Text] [Related]  

  • 22. Perioperative CA19-9 levels can predict stage and survival in patients with resectable pancreatic adenocarcinoma.
    Halm U
    J Clin Oncol; 2006 Dec; 24(35):5610; author reply 5611. PubMed ID: 17158548
    [No Abstract]   [Full Text] [Related]  

  • 23. Myopathy of embolic origin in patients with carcinoma.
    Heffner RR
    Neurology; 1971 Aug; 21(8):840-6. PubMed ID: 5106299
    [No Abstract]   [Full Text] [Related]  

  • 24. [Pulmonary thromboembolism and Clostridium perfringens empyema as the onset of a pancreatic neoplasm].
    Drobnic ME; Román A; Ferrer J; Orriols R
    Med Clin (Barc); 1990 Sep; 95(10):398. PubMed ID: 2084410
    [No Abstract]   [Full Text] [Related]  

  • 25. Serum prostate specific antigen levels are not elevated in most of the patients with advanced pancreatic adenocarcinoma.
    Sawada M; Okada S
    Jpn J Clin Oncol; 1999 Jul; 29(7):365. PubMed ID: 10470664
    [No Abstract]   [Full Text] [Related]  

  • 26. Recurrent ischemic stroke as an initial manifestation of an concealed pancreatic adenocarcinoma: Trousseau's syndrome.
    Giray S; Sarica FB; Arlier Z; Bal N
    Chin Med J (Engl); 2011 Feb; 124(4):637-40. PubMed ID: 21362297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Deep Vein Thrombosis: An Independent Poor Prognosis Factor of Advanced Pancreatic Adenocarcinoma.
    Lambert M; Ploquin A; Declerck L; Duhamel A; Makhloufi S; Turpin A; Truant S; Hebbar M
    Anticancer Res; 2016 Oct; 36(10):5527-5530. PubMed ID: 27798925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of resection of localized pancreaticobiliary adenocarcinoma on angiogenic markers and tissue factor related pro-thrombotic and pro-angiogenic activity.
    Echrish HH; Xiao Y; Madden LA; Allgar V; Cooke J; Wedgwood K; Dasgupta D; Greenman J; Maraveyas A
    Thromb Res; 2014 Aug; 134(2):479-87. PubMed ID: 24929839
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pancreatic adenocarcinoma: a cause of elevated serum beta HCG.
    Yoong W; Subba B; Youssef I; Ojo K; Jarvis K
    J Obstet Gynaecol; 2005 Jan; 25(1):89-91. PubMed ID: 16147719
    [No Abstract]   [Full Text] [Related]  

  • 30. Pancreatic cancer and thrombosis. Highlights from the "2010 ASCO Annual Meeting". Chicago, IL, USA. June 4-8, 2010.
    Shah MM; Saif MW
    JOP; 2010 Jul; 11(4):331-3. PubMed ID: 20601805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biomarkers in pancreatic adenocarcinoma.
    Joza N; Saif MW
    JOP; 2014 Jul; 15(4):308-9. PubMed ID: 25076328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pancreatic panniculitis associated with acinic cell adenocarcinoma: a case report and review of the literature.
    Bogart MM; Milliken MC; Patterson JW; Padgett JK
    Cutis; 2007 Oct; 80(4):289-94. PubMed ID: 18038690
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Response to: Platelet indices in differential diagnosis of pancreatic neuroendocrine tumors from pancreatic adenocarcinomas.
    Karaman K; Kurt M; Aksoy E
    Eur J Intern Med; 2014 Jul; 25(6):e83. PubMed ID: 24873725
    [No Abstract]   [Full Text] [Related]  

  • 34. [Primary pharmacological prevention of thromboembolic events in ambulatory patients with advanced pancreatic cancer treated with chemotherapy?].
    Pelzer U; Sinn M; Stieler J; Riess H
    Dtsch Med Wochenschr; 2013 Oct; 138(41):2084-8. PubMed ID: 24085361
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CA724 is a novel factor for predicting the unresectability in pancreatic adenocarcinoma.
    Liu P; Zhu Y; Liu L
    Int J Clin Exp Pathol; 2015; 8(11):15112-7. PubMed ID: 26823852
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudocyst co-existent with pancreatic adenocarcinoma. A case report.
    Saito S; Toda N; Ishimoto M; Matsumoto M; Niibe H
    Gunma J Med Sci; 1969 Dec; 17(1):132-7. PubMed ID: 5384493
    [No Abstract]   [Full Text] [Related]  

  • 37. Streptococcus bovis septicemia and pancreatic adenocarcinoma.
    Herrington P; Finkelman D; Balart L; Hines C; Ferrante W
    Ann Intern Med; 1980 Mar; 92(3):441. PubMed ID: 7356254
    [No Abstract]   [Full Text] [Related]  

  • 38. [Application of serum protein profiling in diagnosis, prognosis and evaluation of curative effect of pancreatic adenocarcinoma].
    Guo JH; Wang WJ; Liao P; Zhang CY; Jin DY; Lou WH; Zhang SC
    Zhonghua Zhong Liu Za Zhi; 2010 Jan; 32(1):33-6. PubMed ID: 20211064
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Case of large retroperitoneal cyst in the course of adenocarcinoma of the pancreatic tail].
    Pietrzak-Makowska J
    Wiad Lek; 1980 May; 33(10):817-9. PubMed ID: 7405216
    [No Abstract]   [Full Text] [Related]  

  • 40. Prospective evaluation of two tumor-associated proteins in pancreatic adenocarcinoma.
    Bender RA; Weintraub BD; Rosen SW
    Cancer; 1979 Feb; 43(2):591-5. PubMed ID: 421184
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.